AU2018209166B2 - Probiotics for aggregation with disease-associated species in the oral cavity - Google Patents

Probiotics for aggregation with disease-associated species in the oral cavity Download PDF

Info

Publication number
AU2018209166B2
AU2018209166B2 AU2018209166A AU2018209166A AU2018209166B2 AU 2018209166 B2 AU2018209166 B2 AU 2018209166B2 AU 2018209166 A AU2018209166 A AU 2018209166A AU 2018209166 A AU2018209166 A AU 2018209166A AU 2018209166 B2 AU2018209166 B2 AU 2018209166B2
Authority
AU
Australia
Prior art keywords
lactobacillus
microorganism
ncimb
salivarius
gingivalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018209166A
Other languages
English (en)
Other versions
AU2018209166A1 (en
Inventor
Bernd Fiebich
Marcus Rudolf Götz
Kerstin Holmgren
Niklas Larsson
William Wade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Probi AB
Original Assignee
Symrise AG
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise AG, Probi AB filed Critical Symrise AG
Publication of AU2018209166A1 publication Critical patent/AU2018209166A1/en
Application granted granted Critical
Publication of AU2018209166B2 publication Critical patent/AU2018209166B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
AU2018209166A 2017-01-18 2018-01-17 Probiotics for aggregation with disease-associated species in the oral cavity Active AU2018209166B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17152068.7A EP3351259A1 (en) 2017-01-18 2017-01-18 Probiotics for aggregation with disease-associated species in the oral cavity
EP17152068.7 2017-01-18
PCT/EP2018/051112 WO2018134256A1 (en) 2017-01-18 2018-01-17 Probiotics for aggregation with disease-associated species in the oral cavity

Publications (2)

Publication Number Publication Date
AU2018209166A1 AU2018209166A1 (en) 2019-07-18
AU2018209166B2 true AU2018209166B2 (en) 2024-07-18

Family

ID=57868062

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018209166A Active AU2018209166B2 (en) 2017-01-18 2018-01-17 Probiotics for aggregation with disease-associated species in the oral cavity

Country Status (8)

Country Link
US (1) US11338001B2 (enExample)
EP (2) EP3351259A1 (enExample)
JP (1) JP7183165B2 (enExample)
CN (1) CN110769839A (enExample)
AU (1) AU2018209166B2 (enExample)
BR (1) BR112019014161A2 (enExample)
CA (1) CA3048751A1 (enExample)
WO (1) WO2018134256A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112391305B (zh) * 2019-08-15 2023-01-13 上海交通大学 唾液链球菌f286及其用途
CN116528815A (zh) * 2020-12-02 2023-08-01 高露洁-棕榄公司 口腔护理组合物及使用方法
WO2022172230A1 (en) * 2021-02-15 2022-08-18 Blis Technologies Limited Oral composition
CN113957006B (zh) * 2021-09-27 2022-09-30 微康益生菌(苏州)股份有限公司 一种植物乳杆菌n13及其在预防或治疗龋齿和牙周炎上的应用
EP4627937A4 (en) 2022-11-30 2026-03-11 Asahi Group Holdings Ltd COMPOSITION FOR MAINTAINING THE HEALTH OF AN INTRAORAL OR GUMS ENVIRONMENT

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
IL140641A (en) 1998-08-12 2007-07-04 Nestle Sa Incorporation of exogenous lactic bacteria into the oral microflora
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US6986709B2 (en) 2001-09-21 2006-01-17 Igt Gaming device having games with variable game functions
US20050281756A1 (en) 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
EP1659885B1 (en) 2003-08-11 2013-01-16 Oragenics, Inc. Compositions in the maintenance of oral health
EP1634948A1 (en) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP1934328A1 (en) 2005-09-19 2008-06-25 Basf Se Microorganisms inhibiting the formation of foot malodor
KR101300086B1 (ko) 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
ITMI20060860A1 (it) 2006-05-02 2007-11-03 Truffini & Regge Farmaceutici Srl Composizioni per lasalute di denti e gengive contenenti microrganismi eubiotici deidratati rivivificabili
EP2046352A4 (en) 2006-06-06 2012-03-21 Univ Mcgill Fermented milk product and use thereof
CN101190239B (zh) 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
WO2008074473A2 (en) 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutants streptococci
CN102123604A (zh) 2008-06-24 2011-07-13 Wm.雷格利Jr.公司 益生菌口香糖的制造方法
WO2010064373A1 (ja) 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
JP2012512171A (ja) 2008-12-16 2012-05-31 ネステク ソシエテ アノニム 改善された口腔健康のための組成物及び方法
ES2778836T3 (es) 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
DK2455095T3 (en) 2009-07-16 2017-07-24 Univ Hiroshima PROPHYLACTIC, IMPROVING OR THERAPEUTIC AGENT FOR ORAL DISEASES
DE202009011370U1 (de) 2009-08-21 2009-11-19 Dreyer Gmbh Vorrichtung zur Oberflächenbehandlung einer sich bewegenden Kunststoffschicht
DE202009011379U1 (de) 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
CN101703179A (zh) * 2009-12-11 2010-05-12 江南大学 一种清除食品中微囊藻毒素的方法
CN101715908A (zh) * 2009-12-11 2010-06-02 江南大学 一种提高益生菌清除微囊藻毒素效率的方法
DK2364712T3 (da) 2010-03-11 2013-05-21 Kloarys Invest Ltd Topisk, kosmetisk eller farmaceutisk sammensætning, der omfatter probiotiske Lactobacillus-stammer, og anvendelse heraf
TWI383798B (zh) * 2010-04-27 2013-02-01 Syngen Biotech Co Ltd 改善口腔內細菌群的發酵乳酸桿菌ＳＧ－Ａ９５（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｆｅｒｍｅｎｔｕｍ ＳＧ－Ａ９５）及其保健組合物
JP5544234B2 (ja) * 2010-07-23 2014-07-09 森永乳業株式会社 歯周病菌生育抑制用組成物
EP2420580A1 (en) 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
KR101739802B1 (ko) 2010-08-31 2017-05-25 센트로 수페리오 드 인베스티가시온 엔 살루드 퍼블리카 (씨에스아이에스피) 항우식 조성물 및 프로바이오틱/프리바이오틱
TWI572354B (zh) 2010-09-09 2017-03-01 明治股份有限公司 抑制發炎之組成物
US20130344010A1 (en) 2011-01-24 2013-12-26 Basf Se Oral Health Improving Compositions
US9308227B2 (en) 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
JP5904028B2 (ja) 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
MX2015006491A (es) * 2012-11-23 2015-12-03 Seres Health Inc Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
EP2968422A1 (en) 2013-03-14 2016-01-20 Nestec S.A. Lactobacillus plantarum ncc 2936 preparations and oral health
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation
KR101825667B1 (ko) 2014-09-30 2018-02-06 주식회사 알엔에이 비배당체가 세포내에 축적되어 있는 미생물 제제의 제조방법 및 이에 의해 제조된 미생물 제제
JP2018532696A (ja) * 2015-08-25 2018-11-08 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン組成物およびその使用
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
AU2017209868B2 (en) 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity

Also Published As

Publication number Publication date
EP3351259A1 (en) 2018-07-25
EP3570858A1 (en) 2019-11-27
JP2020514309A (ja) 2020-05-21
US11338001B2 (en) 2022-05-24
AU2018209166A1 (en) 2019-07-18
CA3048751A1 (en) 2018-07-26
US20190365833A1 (en) 2019-12-05
JP7183165B2 (ja) 2022-12-05
EP3570858B1 (en) 2021-08-25
WO2018134256A1 (en) 2018-07-26
CN110769839A (zh) 2020-02-07
BR112019014161A2 (pt) 2020-02-11

Similar Documents

Publication Publication Date Title
EP3405205B1 (en) Probiotics for use as anti-inflammatory agents in the oral cavity
JP5143559B2 (ja) う蝕を予防および／または治療するための手段ならびに方法
US10893695B2 (en) Probiotic bacterial strain of Lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP3405563B1 (en) Probiotics for altering the composition of oral biofilms
US11338001B2 (en) Probiotics for aggregation with disease-associated species in the oral cavity
HK1259171B (en) Probiotics for use as anti-inflammatory agents in the oral cavity
HK40000927B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
HK1259176B (en) Probiotics for altering the composition of oral biofilms

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)